Dr. Luther delves into proteinuria, hypertension, heart disease, and the often overlooked hyperaldosteronism as conditions that feature chronic RAAS activation. She explains how each of our therapeutic options—ACE inhibitors, angiotensin II receptor blockers (ARB), spironolactone—are best put to use.